Applied Historical Balance Sheet

APLT Stock

USD 1.24 0.03 2.48%

Trend analysis of Applied Therapeutics balance sheet accounts such as Other Current Liab of 71.3 M, Total Current Liabilities of 74.7 M or Other Liab of 0.0 provides information on Applied Therapeutics' total assets, liabilities, and equity, which is the actual value of Applied Therapeutics to its prevalent stockholders. By breaking down trends over time using Applied Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Applied Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied Therapeutics is a good buy for the upcoming year.

Applied Therapeutics Inventory

(259,875)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

About Applied Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Applied Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Applied Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Applied Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Applied currently owns. An asset can also be divided into two categories, current and non-current.

Applied Therapeutics Balance Sheet Chart

At this time, Applied Therapeutics' Non Current Liabilities Total is comparatively stable compared to the past year. Capital Surpluse is likely to gain to about 293.2 M in 2024, despite the fact that Retained Earnings are likely to grow to (445.2 M).

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Accounts Payable Non Current Assets Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Applied Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Applied Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Applied Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Applied Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Applied Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Applied Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Non Current Liabilities Total is comparatively stable compared to the past year. Capital Surpluse is likely to gain to about 293.2 M in 2024, despite the fact that Retained Earnings are likely to grow to (445.2 M).

	2021	2022	2023	2024 (projected)
Other Current Liabilities	16.1M	27.9M	67.9M	71.3M
Total Assets	89.9M	38.4M	54.8M	56.5M

Other Current Liab Total Assets

Applied Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Capital Lease Obligations	Property Plant And Equipment Gross	Net Receivables	Non Current Liabilities Other
Total Assets		0.54	0.61	0.75	0.89	-0.94	-0.66	0.52	0.96	1.0	0.49	-0.79	0.86	0.86	0.77	0.56	0.76	1.0	0.7	-0.59	-0.54	0.61	-0.55	-0.48	-0.27	-0.56
Other Current Liab	0.54		0.99	-0.14	0.79	-0.73	-0.94	0.05	0.65	0.54	1.0	-0.6	0.85	0.52	0.8	0.99	-0.13	0.54	-0.22	-0.89	-0.97	-0.23	-0.96	-0.97	-0.85	-0.7
Total Current Liabilities	0.61	0.99		-0.06	0.83	-0.77	-0.97	0.2	0.7	0.6	0.99	-0.67	0.89	0.64	0.83	1.0	-0.06	0.61	-0.15	-0.9	-0.98	-0.19	-0.97	-0.97	-0.84	-0.75
Total Stockholder Equity	0.75	-0.14	-0.06		0.42	-0.55	-0.03	0.51	0.62	0.76	-0.2	-0.47	0.35	0.57	0.28	-0.12	1.0	0.75	0.99	0.01	0.13	0.91	0.11	0.21	0.35	-0.08
Net Tangible Assets	0.89	0.79	0.83	0.42		-0.88	-0.88	0.38	0.87	0.88	0.75	-0.73	0.98	0.85	0.9	0.81	0.43	0.89	0.35	-0.83	-0.81	0.27	-0.81	-0.76	-0.63	-0.73
Net Debt	-0.94	-0.73	-0.77	-0.55	-0.88		0.78	-0.37	-0.99	-0.95	-0.69	0.8	-0.9	-0.75	-0.83	-0.73	-0.55	-0.94	-0.48	0.69	0.7	-0.45	0.7	0.66	0.4	0.61
Retained Earnings	-0.66	-0.94	-0.97	-0.03	-0.88	0.78		-0.3	-0.73	-0.65	-0.94	0.72	-0.94	-0.72	-0.93	-0.96	-0.04	-0.67	0.05	0.98	0.98	0.12	0.99	0.97	0.86	0.87
Accounts Payable	0.52	0.05	0.2	0.51	0.38	-0.37	-0.3		0.42	0.48	0.07	-0.6	0.4	0.77	0.39	0.14	0.51	0.52	0.46	-0.28	-0.17	0.22	-0.2	-0.15	-0.02	-0.5
Cash	0.96	0.65	0.7	0.62	0.87	-0.99	-0.73	0.42		0.96	0.61	-0.8	0.87	0.76	0.84	0.66	0.63	0.96	0.56	-0.66	-0.64	0.52	-0.64	-0.58	-0.34	-0.58
Cash And Short Term Investments	1.0	0.54	0.6	0.76	0.88	-0.95	-0.65	0.48	0.96		0.48	-0.77	0.85	0.83	0.76	0.55	0.76	1.0	0.7	-0.57	-0.53	0.63	-0.54	-0.46	-0.25	-0.53
Common Stock Shares Outstanding	0.49	1.0	0.99	-0.2	0.75	-0.69	-0.94	0.07	0.61	0.48		-0.57	0.82	0.51	0.77	0.99	-0.19	0.49	-0.28	-0.88	-0.97	-0.29	-0.96	-0.98	-0.86	-0.7
Non Current Liabilities Total	-0.79	-0.6	-0.67	-0.47	-0.73	0.8	0.72	-0.6	-0.8	-0.77	-0.57		-0.79	-0.85	-0.77	-0.61	-0.47	-0.79	-0.37	0.68	0.63	-0.17	0.64	0.6	0.51	0.63
Capital Surpluse	0.86	0.85	0.89	0.35	0.98	-0.9	-0.94	0.4	0.87	0.85	0.82	-0.79		0.85	0.94	0.86	0.35	0.86	0.27	-0.9	-0.88	0.18	-0.89	-0.84	-0.7	-0.82
Other Current Assets	0.86	0.52	0.64	0.57	0.85	-0.75	-0.72	0.77	0.76	0.83	0.51	-0.85	0.85		0.77	0.58	0.57	0.86	0.49	-0.67	-0.59	0.27	-0.61	-0.55	-0.45	-0.69
Other Stockholder Equity	0.77	0.8	0.83	0.28	0.9	-0.83	-0.93	0.39	0.84	0.76	0.77	-0.77	0.94	0.77		0.81	0.28	0.77	0.2	-0.95	-0.87	0.12	-0.88	-0.83	-0.73	-0.86
Total Liab	0.56	0.99	1.0	-0.12	0.81	-0.73	-0.96	0.14	0.66	0.55	0.99	-0.61	0.86	0.58	0.81		-0.11	0.56	-0.2	-0.89	-0.98	-0.23	-0.97	-0.98	-0.84	-0.73
Net Invested Capital	0.76	-0.13	-0.06	1.0	0.43	-0.55	-0.04	0.51	0.63	0.76	-0.19	-0.47	0.35	0.57	0.28	-0.11		0.76	0.99	0.0	0.12	0.91	0.1	0.2	0.34	-0.09
Total Current Assets	1.0	0.54	0.61	0.75	0.89	-0.94	-0.67	0.52	0.96	1.0	0.49	-0.79	0.86	0.86	0.77	0.56	0.76		0.69	-0.59	-0.54	0.61	-0.55	-0.48	-0.27	-0.56
Net Working Capital	0.7	-0.22	-0.15	0.99	0.35	-0.48	0.05	0.46	0.56	0.7	-0.28	-0.37	0.27	0.49	0.2	-0.2	0.99	0.69		0.09	0.21	0.94	0.19	0.29	0.43	-0.01
Short Long Term Debt Total	-0.59	-0.89	-0.9	0.01	-0.83	0.69	0.98	-0.28	-0.66	-0.57	-0.88	0.68	-0.9	-0.67	-0.95	-0.89	0.0	-0.59	0.09		0.96	0.16	0.97	0.94	0.89	0.91
Property Plant And Equipment Net	-0.54	-0.97	-0.98	0.13	-0.81	0.7	0.98	-0.17	-0.64	-0.53	-0.97	0.63	-0.88	-0.59	-0.87	-0.98	0.12	-0.54	0.21	0.96		0.25	1.0	1.0	0.9	0.84
Current Deferred Revenue	0.61	-0.23	-0.19	0.91	0.27	-0.45	0.12	0.22	0.52	0.63	-0.29	-0.17	0.18	0.27	0.12	-0.23	0.91	0.61	0.94	0.16	0.25		0.23	0.32	0.52	0.07
Capital Lease Obligations	-0.55	-0.96	-0.97	0.11	-0.81	0.7	0.99	-0.2	-0.64	-0.54	-0.96	0.64	-0.89	-0.61	-0.88	-0.97	0.1	-0.55	0.19	0.97	1.0	0.23		0.99	0.9	0.86
Property Plant And Equipment Gross	-0.48	-0.97	-0.97	0.21	-0.76	0.66	0.97	-0.15	-0.58	-0.46	-0.98	0.6	-0.84	-0.55	-0.83	-0.98	0.2	-0.48	0.29	0.94	1.0	0.32	0.99		0.91	0.82
Net Receivables	-0.27	-0.85	-0.84	0.35	-0.63	0.4	0.86	-0.02	-0.34	-0.25	-0.86	0.51	-0.7	-0.45	-0.73	-0.84	0.34	-0.27	0.43	0.89	0.9	0.52	0.9	0.91		0.71
Non Current Liabilities Other	-0.56	-0.7	-0.75	-0.08	-0.73	0.61	0.87	-0.5	-0.58	-0.53	-0.7	0.63	-0.82	-0.69	-0.86	-0.73	-0.09	-0.56	-0.01	0.91	0.84	0.07	0.86	0.82	0.71

Click cells to compare fundamentals

Applied Therapeutics Account Relationship Matchups

Applied Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	48.4M	104.5M	89.9M	38.4M	54.8M	56.5M
Other Current Liab	264K	19.8M	16.1M	27.9M	67.9M	71.3M
Total Current Liabilities	14.1M	21.2M	26.5M	33.4M	71.2M	74.7M
Total Stockholder Equity	32.6M	81.9M	62.5M	4.1M	(17.1M)	(16.3M)
Net Tangible Assets	(19.6M)	32.6M	81.9M	62.5M	71.9M	75.5M
Net Debt	(16.8M)	(55.7M)	(52.6M)	(15.8M)	(49.1M)	(46.7M)
Retained Earnings	(66.8M)	(160.7M)	(266.3M)	(348.8M)	(468.6M)	(445.2M)
Accounts Payable	8.8M	640K	9.5M	4.5M	1.7M	1.7M
Cash	18.9M	57.5M	53.9M	16.7M	49.9M	34.4M
Non Current Assets Total	2.2M	1.9M	1.5M	1.1M	447K	424.7K
Other Assets	199K	1.9M	200K	1.0	1.15	1.09
Cash And Short Term Investments	38.9M	96.8M	80.8M	30.6M	49.9M	50.1M
Common Stock Shares Outstanding	12.8M	22.0M	25.6M	37.8M	84.2M	88.5M
Liabilities And Stockholders Equity	48.4M	104.5M	89.9M	38.4M	54.8M	56.5M
Non Current Liabilities Total	1.7M	1.3M	891K	878K	797K	1.4M
Other Current Assets	7.3M	5.3M	7.0M	6.5M	4.2M	5.0M
Other Stockholder Equity	51.0M	242.8M	329.0M	352.8M	451.4M	230.2M
Total Liab	15.8M	22.6M	27.4M	34.3M	72.0M	75.6M
Net Invested Capital	32.6M	83.0M	63.3M	5.1M	(16.8M)	(16.0M)
Total Current Assets	46.2M	102.6M	88.4M	37.3M	54.4M	55.4M
Accumulated Other Comprehensive Income	(2K)	(112K)	(107K)	51K	45.9K	48.2K
Net Working Capital	32.1M	81.4M	61.9M	3.9M	(16.8M)	(16.0M)
Short Term Debt	356K	812K	884K	954K	858K	607.2K
Common Stock	1K	2K	3K	5K	8K	8.4K
Capital Stock	1K	2K	3K	5K	8K	8.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Applied Historical Balance Sheet

Applied Therapeutics Inventory

(259,875)

About Applied Balance Sheet Analysis

Applied Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Non Current Assets Total

Applied Therapeutics balance sheet Correlations

Applied Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Applied Therapeutics balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Applied Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Common Stock Shares Outstanding	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Cash	- 0.99	Net Debt
Property Plant And Equipment Gross	- 0.98	Total Liab
Property Plant And Equipment Net	- 0.98	Total Liab
Property Plant And Equipment Gross	- 0.98	Common Stock Shares Outstanding
Property Plant And Equipment Net	- 0.98	Total Current Liabilities
Capital Lease Obligations	- 0.97	Total Liab